| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Li,Shu-Hui | Chairman | 5.01% | |
| Shi,Ge-Rui | Director | 11.16% | |
| Center Laboratories, Inc. | Director | 16.86% | |
| BHUSHAN DHRUVKUMAR DESAI | Director | 5.16% | |
| Lai,Ya-De | Independent Director | 0.00% | |
| Qiu,Jing-Fei | Independent Director | 0.00% | |
| PETER KEIL | Independent Director | 0.00% |
| 項目 | 2024 | 2023 |
|---|---|---|
| Operating income | 700 | 2,319 |
| Operating cost | 68 | 89 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - |
| Operating gross profit (loss) | 632 | 2,230 |
| Unrealized profit (loss) on sales of goods | - | - |
| Realized profit (loss) on sales of goods | - | - |
| Operating gross profit (loss), net | 632 | 2,230 |
| Operating expenses | 29,637 | 30,846 |
| Other gain (loss), net | - | - |
| Operating profit (loss) | -29,005 | -28,616 |
| Non-operating income and expenses | -985 | 568 |
| Net profit (loss) before tax | -29,990 | -28,048 |
| Income tax expense (benefits) | 97 | 32 |
| Net profit (loss) of ongoing business for the current period | -30,087 | -28,080 |
| Profit (loss) of closed units | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - |
| Net profit (loss) for the current period | -30,087 | -28,080 |
| Other comprehensive profit (loss), net | -217 | -7 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - |
| Total comprehensive profit and loss for the current period | -30,304 | -28,087 |
| Net profit (loss) attributable to owners of parent company | -30,073 | -28,079 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - |
| Net profit (loss) attributable to non-controlling interests | -14 | -1 |
| Comprehensive profit (loss) attributable to owners of parent company | -30,239 | -28,085 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -65 | -2 |
| Basic earnings per share (yuan) | -1 | -12 |
| 項目 | 2024 | 2023 |
|---|---|---|
| Net cash inflow (outflow) from operating activities | -15,952 | -24,132 |
| Net cash inflows (outflows) from investing activities | -927 | -4,359 |
| Net cash inflow (outflow) from financing activities | 471,575 | 37,885 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1,820 | -4 |
| Increase (decrease) in cash and cash equivalents in the current period | 456,516 | 9,390 |
| Beginning balance of cash and cash equivalents | 11,456 | 2,066 |
| Ending balance of cash and cash equivalents | 467,972 | 11,456 |
| 項目 | 2024 | 2023 |
|---|---|---|
| Current asset | 489,922 | 13,029 |
| Non-current asset | 12,762 | 9,202 |
| Total asset | 502,684 | 22,231 |
| Current liability | 25,686 | 105,414 |
| Non-current liability | 3,359 | 79 |
| Total liability | 29,045 | 105,493 |
| share capital | 188,852 | 8,770 |
| Equity - secruity token | - | - |
| capital reserve | 423,503 | 16,380 |
| retained earning | -138,458 | -108,385 |
| Other equity | -207 | -41 |
| Treasury stock | - | - |
| Total equity attributable to owners of parent company | 473,690 | -83,276 |
| Equity attributable to former owner of business combination under common control | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - |
| Non-controlling interests | -51 | 14 |
| Total Equity | 473,639 | -83,262 |
| Share capital awaiting retirement (unit: share) | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 |
| Net asset value per share | 25 | -94 |
